A Single-center, Randomized, Double-blind, Placebo-controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a V112054 Liquid Oral Formulation Following in Healthy Male Adults (CSB1001)

Authors

Jeffrey L. Huston, Cedarville UniversityFollow

Role

Pharmacist

Sponsor

Purdue Pharma, L.P.

Location

Stamford, CT

Recommended Citation

Huston, Jeffrey L., "A Single-center, Randomized, Double-blind, Placebo-controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a V112054 Liquid Oral Formulation Following in Healthy Male Adults (CSB1001)" (2004). Pharmacy Faculty Research. 12.
https://digitalcommons.cedarville.edu/pharmacy_research/12